However, the frequency of tumors with MLH1, MGMT, and p16INK4a hypermethylation agreed with previously published reports, indicating that the patients constituted a representative colon cancer cohort with regard to methylation profiles. This evidence concerns the gene CDKN2A and colonic neoplasm.